// App-Quantinova.ai

1913 : Lysyl Oxidase Induces Fibrosis Via Upregulation of IL-6 and Serves As a Biomarker to Monitor Response to Therapy

Researchers

Presenter

  • Tetsuya Nishimoto

Principal Investigators

  • Takahisa Takihara

  • Logan Mlakar

  • Carol Feghali-Bostwick

Medical Centers

  • Tokai University School of Medicine, Isehara, Japan

  • Medcl Univ of South Carolina, Charleston, SC

  • College of Medicine, Medical University of South Carolina, Charleston, SC

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Interleukin 6

Drug/Treatment

  • DE-074

  • M2ES

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved